Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$104,804,529
+$2,467,280 QoQ
Shares Held
412,665
-1.4% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#292
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 63%
Shared 0%
None 37%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEAPACK GLADSTONE FINANCIAL CORP holds $425,890,657 across 14 Drug Manufacturers - General names. JNJ ranks #1 (24.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
412,665 | $104,804,529 | |
| 2 | LLY |
ELI LILLY & Co
|
78,019 | $93,578,336 | |
| 3 | MRK |
Merck & Co., Inc.
|
563,132 | $72,362,462 | |
| 4 | ABBV |
AbbVie Inc.
|
209,332 | $52,676,303 | |
| 5 | AMGN |
Amgen Inc
|
87,050 | $31,522,545 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
439,307 | $25,312,868 | |
| 7 | PFE |
Pfizer Inc
|
879,706 | $21,183,319 | |
| 8 | AZN |
Astrazeneca PLC
|
72,990 | $13,840,363 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,804,529 | 412,665 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $102,337,249 | 418,660 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $89,242,840 | 431,229 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $79,741,724 | 430,060 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $65,448,181 | 428,466 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $72,574,070 | 437,615 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $62,382,125 | 431,352 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $71,943,942 | 443,934 | Shares | Defined | 2024-11-26 | |
| 2024-06-30 | $65,575,121 | 448,653 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $73,320,115 | 463,494 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $73,487,704 | 468,851 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $73,790,455 | 473,775 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $78,774,939 | 475,924 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $73,534,945 | 474,419 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $85,503,898 | 484,030 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $80,816,478 | 494,714 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $71,941,073 | 405,279 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $72,714,455 | 410,283 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $70,328,073 | 411,107 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $66,291,874 | 410,476 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $57,444,012 | 348,695 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $57,627,518 | 350,639 | Shares | Other | 2021-05-14 | |
| 2020-12-31 | $52,767,467 | 335,287 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $54,005,325 | 362,744 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $50,919,450 | 362,081 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $47,432,604 | 361,722 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||